SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is gaining attention as community members actively discuss potential airdrops and burns to increase token value. The community is focused on utility and real-world traction, coining the term "pre-rich". Linked to Solana, the coin is getting mentions alongside other meme coins and WAGMI.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions around its potential within the broader crypto market, particularly in relation to new ETFs. Community members are actively debating price movements and future potential, with some anticipating a significant rise, while others express concerns about short-term volatility. The launch of a Hong Kong spot ETF has also spurred interest in the Asian market.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending following strong earnings results, especially in its cloud services (AWS), fueling optimism and pushing the stock to new highs. The community is actively discussing potential price targets and whether this rally will hold, with some analysts forecasting further gains. Some are noting the company's layoffs despite strong earnings, while others point to the company's historically lagging performance as a reason for excitement.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the community anticipates the impact of earnings and discusses the company's bitcoin holdings relative to its stock price. Bullish sentiment seems to be building with some traders betting on a run-up, while others remain skeptical of the company's long-term prospects and business model, especially with recent price action.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members rally around the narrative that 'we are all Satoshi,' viewing the token as more than a meme, but a movement and a cultural phenomenon. Many believe $SATOSHI represents the core of crypto culture and possesses limitless potential, drawing parallels to Bitcoin itself. A potential upcoming appearance at the Mario Nawfal Roundtable is adding to the excitement.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

Solid Power ($SLDP) is trending amid discussions about its partnerships with Samsung SDI, BMW, and SK On for developing all-solid-state batteries (ASSB), with community members debating the implications of these collaborations on scaling ASSB technology. Bullish investors emphasize the company's potential in the solid-state battery market, highlighting its partnerships and pilot production factory, while bears express concerns about pressure demands, moisture sensitivity, and competition from other battery technologies.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending amid news of increased competition and political pressure on drug pricing, sparking concerns about future profitability. The community is actively discussing the potential impact of these factors on NVO's market position, especially relative to competitors like Eli Lilly ($LLY).  Mergers and acquisitions may factor into the future of the company as it navigates the evolving landscape of the weight loss drug market.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid speculation of a potential sale, with SpaceX cited as a possible buyer, and the community is buzzing about the implications for Apple, a major partner. Discussions revolve around potential bidding wars and the true value of Globalstar's spectrum, with some suggesting a buyout could be significantly higher than current market capitalization. The potential sale could reshape the satellite communications landscape, especially given Globalstar's existing relationship with Apple.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid renewed speculation of a potential buyout, sparking heavy trading volume. The community is actively discussing possible acquirers, potential deal valuations, and the impact on current shareholders. Bullish sentiment also stems from pipeline progress outside of COVID vaccines, though some caution against over-optimism.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's after-hours trading is active as investors digest the latest earnings report. Community discussions are centering on iPhone sales performance, guidance for the next quarter, and the impact of AI investments. Revenue from China is a key point of concern amid otherwise positive results.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure's ProSense Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances

IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in Breast Cancer Care' Roundtable Highlighting Cryoablation Advances IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in...

IceCure Medical to Attend the 2025 Maxim Growth Summit

IceCure Medical to Attend the 2025 Maxim Growth Summit IceCure Medical to Attend the 2025 Maxim Growth Summit PR Newswire CAESAREA, Israel, Oct. 9, 2025 IceCure recently achieved a significant...

ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment

IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.

Shares of IceCure Medical (ICCM) went as high as $1.4 on Friday afternoon before paring back gains after the U.S. Food and Drug Administration granted marketing authorization for ProSense, a minimally invasive cryoablation treatment.ProSense is for patients aged 70 and over with early-stage low-risk breast cancer and treated with adjuvant endocrine therapy. It is the first and only medical device to receive FDA marketing authorization for the local treatment of breast cancer, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.icecure-medical.com/news-events/press-releases/detail/191/icecure-medicals-prosense-cryoablation-granted-fda-marketing-authorization-for-treatment-of-low-risk-breast-cancer-in-women-aged-70-and-above-significant-development-in-giving-women-with-breast-cancer-minimally-invasive-care">stated</a>.During the ProSense cryoablation procedure, a doctor injects local anesthesia and uses ultrasound imaging to guide a small cryoprobe, a thin hollow needle, into the breast tumor. Once the cryoprobe is placed, liquid nitrogen creates extremely cold temperatures, which destroy the breast tumor by creating an ice ball around the targeted tissue.The approval of the treatment was based on data, including a multi-centre clinical trial with 194 patients. Only 3.1% of patients with hormone receptor-positive and HER2-breast cancer treated locally with cryoablation and endocrine therapy experienced local recurrence of breast cancer within five years after treatment in the study, IceCure said.The company, however, stated that the FDA has requested it conduct a post-market surveillance study to generate additional data. The post-market study is expected to include approximately 400 patients, IceCure said.IceCure lists several benefits to its treatment, including maintenance of breast shape, a short, outpatient procedure, and reduced recovery time. The majority of adverse events identified in studies were swelling, bruising, hematoma, skin burn, and postoperative pain, which were mild in severity, it added.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ICCM">ICCM stock</a> soared from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:576/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_2_00_01_PM_png_a1d54603d1.webp" alt="ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits" width="576" height="61"><figcaption>ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits</figcaption></figure>ICCM stock is down 4% this year but up by about 74% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rocket-pharma-stock-gets-price-target-cut-after-withdrawing-fda-application-for-rare-bone-marrow-disorder-gene-therapy/chCuqQ5R3Qm">Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

IceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA Approval

The company stated that the FDA has requested it conduct a post-market surveillance study to generate additional data.

Equity

IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates

IceCure Medical (ICCM) delivered earnings and revenue surprises of +200.00% and -34.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates

Viatris (VTRS) delivered earnings and revenue surprises of +10.71% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates

Labcorp (LH) delivered earnings and revenue surprises of +5.07% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation...

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Icecure Medical Ltd

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

Current Price	$0.71
Prev Close	$0.7468
Open	$0.722
Dividend Yield	0.00%
50-Day Moving Average	$0.9569
Beta	0.37
Avg. Volume	1.1M
PE Ratio	-2.58

52-Week High	$1.66
52-Week Low	$0.5341
Market Capitalization	$48.77M
EPS (Annual)	-$0.2954
Price to Book	14.69
Revenue Per Employee	$45,708.33
Enterprise Value/EBITDA	N/A

ICCM
Icecure Medical Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ICCM News

ICCMIcecure Medical Ltd